Department of Health and Human Services June 2009 – Federal Register Recent Federal Regulation Documents

Results 151 - 200 of 315
Notice of Public Meeting To Discuss NIOSH's Respirator Standards Development Efforts
Document Number: E9-14085
Type: Notice
Date: 2009-06-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and prevention (CDC), will conduct a public meeting to discuss current respirator standards development projects for Supplied Air Respirators (SAR); Air Fed Ensembles; and Total Inward Leakage (TIL) for respirators other than filtering facepieces and halfmasks. There will be an opportunity for discussion following NIOSH's presentations and an accompanying poster session.
Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: E9-14084
Type: Notice
Date: 2009-06-16
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644).
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: E9-14080
Type: Notice
Date: 2009-06-16
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ``CAHPS Field Test of Proposed Health Information Technology Questions and Methodology.'' In accordance with the Paperwork Reduction Act of 1995, Public Law 104-13 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: E9-14079
Type: Notice
Date: 2009-06-16
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ``2010-2011 Medical Expenditure Panel Survey Insurance Component.'' In accordance with the Paperwork Reduction Act of 1995, 44 U.S.C. 3506(c)(2)(A), AHRQ invites the public to comment on this proposed information collection.
Agency Emergency Processing Under Office of Management and Budget Review; Reporting and Recordkeeping Requirements for Reportable Food Registry
Document Number: E9-14048
Type: Notice
Date: 2009-06-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for emergency processing under the Paperwork Reduction Act of 1995 (the PRA). This notice solicits comments on the proposed collection of information associated with the draft guidance document entitled ``Questions and Answers Regarding the Reportable Food Registry as Established by the Food and Drug Administration Amendments Act of 2007.'' The draft guidance, when finalized, will assist the industry in complying with the Reportable Food Registry requirements prescribed by the Food and Drug Administration Amendments Act of 2007 (FDAAA).
Office of Urban Indian Health Programs
Document Number: E9-14044
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, Indian Health Service
Determination That THORAZINE (Chlorpromazine Hydrochloride) Injection and 18 Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Document Number: E9-14000
Type: Notice
Date: 2009-06-15
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) has determined that the 19 drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements.
Submission for OMB Review; Comment Request
Document Number: E9-13985
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
National Center for Research Resources; Amended Notice of Meeting
Document Number: E9-13950
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: E9-13949
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Document Number: E9-13948
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: E9-13947
Type: Notice
Date: 2009-06-15
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Document Number: E9-13946
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: E9-13944
Type: Notice
Date: 2009-06-15
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Government-Owned Inventions; Availability for Licensing
Document Number: E9-13943
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of Federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
National Human Genome Research Institute; Notice of Closed Meeting
Document Number: E9-13941
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Document Number: E9-13940
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: E9-13939
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: E9-13935
Type: Notice
Date: 2009-06-15
Agency: Department of Health and Human Services, National Institutes of Health
Mary E. Sawaya a.k.a. Marty Sawaya; Debarment Order
Document Number: E9-13929
Type: Notice
Date: 2009-06-12
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the act) permanently debarring Dr. Mary E. Sawaya a.k.a. Marty Sawaya (Dr. Sawaya) from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Dr. Sawaya was convicted of a felony under Federal law for conduct relating to the development or approval, including the process for development or approval, of a drug product, and conduct otherwise relating to the regulation of a drug product under the act. After being given notice of the proposed permanent debarment and an opportunity to request a hearing within the timeframe prescribed by regulation, Dr. Sawaya failed to request a hearing. Dr. Sawaya's failure to request a hearing constitutes a waiver of her right to a hearing concerning this action.
New Animal Drugs for Use in Animal Feeds; Chlortetracycline
Document Number: E9-13849
Type: Rule
Date: 2009-06-12
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for revised Blue Bird labeling for chlortetracycline Type A medicated articles used to formulate Type B and Type C medicated feeds in various classes of livestock and poultry.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: E9-13841
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
National Cancer Institute; Notice of Closed Meeting
Document Number: E9-13768
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, National Institutes of Health
Allyn M. Norman; Debarment Order
Document Number: E9-13766
Type: Notice
Date: 2009-06-12
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the act) debarring Dr. Allyn M. Norman for 5 years from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Dr. Norman was convicted of a misdemeanor under Federal law for conduct relating to the development or approval, including the process for development or approval, of a drug product or otherwise relating to the regulation of drug products under the act, and that the type of conduct that served as the basis for the conviction undermines the process for the regulation of drugs. Dr. Norman failed to request a hearing and, therefore, has waived his opportunity for a hearing concerning this action.
National Institute of Mental Health; Notice of Closed Meetings
Document Number: E9-13762
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice of Closed Meetings
Document Number: E9-13761
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
Document Number: E9-13760
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
Document Number: E9-13759
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed Meeting
Document Number: E9-13756
Type: Notice
Date: 2009-06-12
Agency: Department of Health and Human Services, National Institutes of Health
Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting
Document Number: E9-13767
Type: Notice
Date: 2009-06-11
Agency: Food and Drug Administration, Department of Health and Human Services
National Institute of General Medical Sciences; Notice of Closed Meeting
Document Number: E9-13758
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed Meeting
Document Number: E9-13757
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
Submission for OMB Review; Comment Request
Document Number: E9-13728
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Implementation of the Animal Generic Drug User Fee Act of 2008; User Fee Cover Sheet Form FDA 3728
Document Number: E9-13716
Type: Notice
Date: 2009-06-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
Draft Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2008 [Correction]
Document Number: E9-13694
Type: Notice
Date: 2009-06-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP)
Document Number: E9-13692
Type: Notice
Date: 2009-06-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Oral Dosage Form New Animal Drugs; Methimazole
Document Number: E9-13685
Type: Rule
Date: 2009-06-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the original approval of a new animal drug application (NADA) filed by Dechra, Ltd. The NADA provides for the veterinary prescription use of methimazole tablets in cats for treatment of hyperthyroidism.
Proposed Information Collection Activity; Comment Request
Document Number: E9-13684
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Center for Scientific Review; Notice of Closed Meetings
Document Number: E9-13682
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: E9-13681
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Document Number: E9-13680
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: E9-13679
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: E9-13678
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
Document Number: E9-13677
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of Closed Meeting
Document Number: E9-13676
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
Document Number: E9-13668
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services, National Institutes of Health
Announcement of Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020
Document Number: E9-13635
Type: Notice
Date: 2009-06-11
Agency: Department of Health and Human Services
The U.S. Department of Health and Human Services (HHS) announces the next Federal advisory committee meeting regarding the national health promotion and disease prevention objectives for 2020. This meeting will be open to the public and will be held online via WebEx software. The Secretary's Advisory Committee on National Health Promotion and
Draft Guidance for Industry: Questions and Answers Regarding the Reportable Food Registry as Established by the Food and Drug Administration Amendments Act of 2007; Availability; Announcement of Further Delay in Implementation of the Food and Drug Administration Amendments Act of 2007
Document Number: E9-13614
Type: Notice
Date: 2009-06-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled ``Guidance for Industry: Questions and Answers Regarding the Reportable Food Registry as Established by the Food and Drug Administration Amendments Act of 2007.'' The draft guidance, when finalized, will assist the industry in complying with the Reportable Food Registry requirements prescribed by the Food and Drug Administration Amendments Act of 2007 (FDAAA). FDA is also announcing a further delay in the implementation of the Reportable Food Registry (the Registry) of FDAAA until September 8, 2009, to consider any comments received on the draft guidance and through the agency's planned outreach initiatives, and to allow for further testing of the electronic portal for reportable foods.
National Institute for Occupational Safety and Health; Decision To Evaluate a Petition To Designate a Class of Employees for the Norton Company in Worcester, MA, To Be Included in the Special Exposure Cohort
Document Number: E9-13662
Type: Notice
Date: 2009-06-10
Agency: Department of Health and Human Services
HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees for the Norton Company in Worcester, Massachusetts, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows:
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.